Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01951690
Title Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center, Anschutz Medical Campus Denver Colorado 80045 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Washington University School of Medicine St. Louis Missouri 63110 United States Details
Knight Cancer Institute, Oregon Health and Science University Portland Oregon 97239 United States Details
University of Pittsburgh Medical Center Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390-8852 United States Details
The University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field